CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

EpilepsyGTx and ClearPoint Neuro join forces on targeted therapy

PartnershipEPY201Positive
AI Analysis

Summary

EpilepsyGTx and ClearPoint Neuro announced a partnership to support the first-in-human trial of EPY201, a targeted therapy for epilepsy.

Clinical Trial Data

Phase

Phase_1

Importance:6/10
Sentiment:
0.40
PartnershipClinical TrialTargeted TherapyEpilepsyFirst-in-Human
Related Companies

Read the original article

Published by PharmaTimes on July 16, 2026 12:37 PM

Read Original